Komissarov Andrey A, Florova Galina, Azghani Ali O, Buchanan Ann, Bradley William M, Schaefer Chris, Koenig Kathleen, Idell Steven
The Department of Cellular and Molecular Biology and the Texas Lung Injury Institute, The University of Texas Health Science Center at Tyler (UTHSCT), Tyler, Texas;
The Department of Biology at the University of Texas at Tyler, Tyler, Texas;
Am J Physiol Lung Cell Mol Physiol. 2015 Sep 15;309(6):L562-72. doi: 10.1152/ajplung.00136.2015. Epub 2015 Jul 10.
The time required for the effective clearance of pleural adhesions/organization after intrapleural fibrinolytic therapy (IPFT) is unknown. Chest ultrasonography and computed tomography (CT) were used to assess the efficacy of IPFT in a rabbit model of tetracycline-induced pleural injury, treated with single-chain (sc) urokinase plasminogen activators (scuPAs) or tissue PAs (sctPA). IPFT with sctPA (0.145 mg/kg; n = 10) and scuPA (0.5 mg/kg; n = 12) was monitored by serial ultrasonography alone (n = 12) or alongside CT scanning (n = 10). IPFT efficacy was assessed with gross lung injury scores (GLIS) and ultrasonography scores (USS). Pleural fluids withdrawn at 0-240 min and 24 h after IPFT were assayed for PA and fibrinolytic activities, α-macroglobulin/fibrinolysin complexes, and active PA inhibitor 1 (PAI-1). scuPA and sctPA generated comparable steady-state fibrinolytic activities by 20 min. PA activity in the scuPA group decreased slower than the sctPA group (kobs = 0.016 and 0.042 min(-1)). Significant amounts of bioactive uPA/α-macroglobulin (but not tPA; P < 0.05) complexes accumulated at 0-40 min after IPFT. Despite the differences in intrapleural processing, IPFT with either fibrinolysin was effective (GLIS ≤ 10) in animals imaged with ultrasonography only. USS correlated well with postmortem GLIS (r(2) = 0.85) and confirmed relatively slow intrapleural fibrinolysis after IPFT, which coincided with effective clearance of adhesions/organization at 4-8 h. CT scanning was associated with less effective (GLIS > 10) IPFT and higher levels of active PAI-1 at 24 h following therapy. We concluded that intrapleural fibrinolysis in tetracycline-induced pleural injury in rabbits is relatively slow (4-8 h). In CT-scanned animals, elevated PAI-1 activity (possibly radiation induced) reduced the efficacy of IPFT, buttressing the major impact of active PAI-1 on IPFT outcomes.
胸膜内纤维蛋白溶解疗法(IPFT)后有效清除胸膜粘连/机化所需的时间尚不清楚。在四环素诱导的胸膜损伤兔模型中,使用胸部超声和计算机断层扫描(CT)来评估IPFT的疗效,该模型用单链(sc)尿激酶型纤溶酶原激活剂(scuPAs)或组织型纤溶酶原激活剂(sctPA)进行治疗。单独通过连续超声检查(n = 12)或联合CT扫描(n = 10)监测sctPA(0.145 mg/kg;n = 10)和scuPA(0.5 mg/kg;n = 12)的IPFT。用总肺损伤评分(GLIS)和超声评分(USS)评估IPFT疗效。在IPFT后0 - 240分钟和24小时抽取的胸水检测纤溶酶原激活剂(PA)和纤溶活性、α-巨球蛋白/纤溶酶复合物以及活性PA抑制剂1(PAI-1)。scuPA和sctPA在20分钟时产生了相当的稳态纤溶活性。scuPA组的PA活性下降比sctPA组慢(观测速率常数分别为0.016和0.042分钟⁻¹)。IPFT后0 - 40分钟有大量生物活性尿激酶型纤溶酶原激活剂/α-巨球蛋白(而非组织型纤溶酶原激活剂;P < 0.05)复合物积累。尽管胸膜内处理存在差异,但仅用超声成像的动物中,使用任何一种纤溶酶进行IPFT都是有效的(GLIS≤10)。USS与死后GLIS相关性良好(r² = 0.85),并证实IPFT后胸膜内纤溶相对缓慢,这与4 - 8小时粘连/机化的有效清除相吻合。CT扫描与疗效较差(GLIS > 10)的IPFT相关,且治疗后24小时活性PAI-1水平较高。我们得出结论,兔四环素诱导的胸膜损伤中胸膜内纤溶相对缓慢(4 - 8小时)。在CT扫描的动物中,PAI-1活性升高(可能是辐射诱导)降低了IPFT的疗效,这支持了活性PAI-1对IPFT结果的主要影响。